Free Trial

VAREX IMAGING (NASDAQ:VREX) Short Interest Down 23.5% in August

VAREX IMAGING logo with Medical background

Key Points

  • VAREX IMAGING's short interest decreased by 23.5% in August, totaling 933,300 shares as of August 31st, down from 1,220,000 shares.
  • The company reported $0.18 EPS for the last quarter, significantly outperforming the consensus estimate of $0.04 and achieving revenues of $203 million compared to expected revenue of $190.32 million.
  • Analysts have mixed views on VAREX IMAGING, with B. Riley maintaining a "buy" rating and a target price increase from $12.00 to $16.00, while Wall Street Zen lowered its rating from "strong-buy" to "buy."
  • MarketBeat previews the top five stocks to own by October 1st.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 933,300 shares, a drop of 23.5% from the August 15th total of 1,220,000 shares. Approximately 2.3% of the company's shares are short sold. Based on an average daily volume of 427,400 shares, the days-to-cover ratio is currently 2.2 days. Based on an average daily volume of 427,400 shares, the days-to-cover ratio is currently 2.2 days. Approximately 2.3% of the company's shares are short sold.

Analyst Ratings Changes

VREX has been the topic of several recent analyst reports. B. Riley reissued a "buy" rating and set a $16.00 price objective (up previously from $12.00) on shares of VAREX IMAGING in a research note on Friday, August 8th. Wall Street Zen downgraded shares of VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $19.50.

Read Our Latest Report on VAREX IMAGING

Hedge Funds Weigh In On VAREX IMAGING

Several large investors have recently bought and sold shares of the stock. Quarry LP purchased a new stake in shares of VAREX IMAGING during the 1st quarter valued at $63,000. ProShare Advisors LLC purchased a new stake in shares of VAREX IMAGING during the 4th quarter valued at $159,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of VAREX IMAGING by 58.0% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,279 shares of the company's stock valued at $131,000 after purchasing an additional 4,139 shares during the last quarter. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of VAREX IMAGING during the 4th quarter valued at $190,000. Finally, BNP Paribas Financial Markets increased its position in shares of VAREX IMAGING by 18.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company's stock valued at $113,000 after purchasing an additional 2,036 shares during the last quarter.

VAREX IMAGING Trading Down 0.5%

NASDAQ:VREX traded down $0.06 on Friday, reaching $12.28. 763,745 shares of the stock traded hands, compared to its average volume of 327,101. The firm has a market capitalization of $509.62 million, a price-to-earnings ratio of -3.83 and a beta of 0.87. The company's 50 day moving average is $9.86 and its 200-day moving average is $9.32. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78. VAREX IMAGING has a 1-year low of $6.76 and a 1-year high of $16.93.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.14. The business had revenue of $203.00 million during the quarter, compared to the consensus estimate of $190.32 million. VAREX IMAGING had a negative net margin of 16.13% and a positive return on equity of 5.54%. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. Equities research analysts anticipate that VAREX IMAGING will post 0.53 EPS for the current fiscal year.

About VAREX IMAGING

(Get Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Further Reading

Should You Invest $1,000 in VAREX IMAGING Right Now?

Before you consider VAREX IMAGING, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VAREX IMAGING wasn't on the list.

While VAREX IMAGING currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.